COPENHAGEN — Europe’s choppy vaccine rollout hit more trouble on Wednesday after U.S. drugmaker Johnson & Johnson delayed its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over the risk of blood clotting.
The European Medicines Agency (EMA) said it expected to issue a recommendation on Johnson & Johnson’s vaccine next week but that it continued to believe the benefits of the shot outweighed the risks of side effects.
U.S. federal health agencies recommended pausing use of the vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot.
Deliveries had already begun in some Europea…
Keep on reading: Europe’s vaccine rollout hit by doubts over J&J, AstraZeneca shots